Australia's largest stock trading and investment forum Australia's #1 stock forum

TIS

Click for more information

0.00%

0.0¢ tissue therapies limited

Rev - Rev - what court are you talking about? The court's name,...

First 5 Last

Share
Profile

Follow
CroMagnon

264 Posts.

3

06/05/15

16:26

Post #: 15229135
Share

Rev -

Originally posted by Revreboot ↑

I agree Tim. I think the evidence points towards the EMA being deliberately obstructionist - probably because they were forced by the court to treat VG as a device. The minutes of the EMA meeting (where the first list of questions was handed down) stated this:

"Furthermore the members discussed some procedural aspects relating to the CE mark classification."

I wonder what was discussed and whether some sort of plan was formulated to frustrate the application.

They handed down a list of questions to answer in January 2014.
They handed down a list of outstanding issues in September 2014.
They delayed the TIS response to the issues in November 2014 until January.
They delayed it again in January 2015 until February.
At some stage between the end of February and the end of March the EMA decided not to proceed by way of the usual process but to instead proceed by way of oral examination.

In hindsight the signs were clear that EMA did not want anything to do with VG. I wish I had read those signs correctly at the time.

Rev

Expand

Rev - what court are you talking about?
The court's name, case number and findings would certainly go a long way in substantiating your statement.

TIS Price at posting: 8.7¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MTM

Australian Rare Earths bullish on early-stage uranium potential at Overland, SA

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

SHN

Chimeric clocks $4.17M R&D tax rebate from Canberra

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Chaos reigns markets – so let's take stock of where we're at ahead of December

OCN

Southern Cross Gold zooms in on 9 new high-grade zones above 20g/t at Golden Dyke

PME

Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals

Watchdog takes Webjet to court over alleged 'false' flight prices with hidden fees

There are more pages in this discussion • 12 more messages in this thread...

First 5 Last

Add TIS (ASX) to my watchlist